Correlation Between Tff Pharmaceuticals and Molecular Partners
Can any of the company-specific risk be diversified away by investing in both Tff Pharmaceuticals and Molecular Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tff Pharmaceuticals and Molecular Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tff Pharmaceuticals and Molecular Partners AG, you can compare the effects of market volatilities on Tff Pharmaceuticals and Molecular Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tff Pharmaceuticals with a short position of Molecular Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tff Pharmaceuticals and Molecular Partners.
Diversification Opportunities for Tff Pharmaceuticals and Molecular Partners
-0.05 | Correlation Coefficient |
Good diversification
The 3 months correlation between Tff and Molecular is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Tff Pharmaceuticals and Molecular Partners AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Partners and Tff Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tff Pharmaceuticals are associated (or correlated) with Molecular Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Partners has no effect on the direction of Tff Pharmaceuticals i.e., Tff Pharmaceuticals and Molecular Partners go up and down completely randomly.
Pair Corralation between Tff Pharmaceuticals and Molecular Partners
Given the investment horizon of 90 days Tff Pharmaceuticals is expected to under-perform the Molecular Partners. In addition to that, Tff Pharmaceuticals is 1.39 times more volatile than Molecular Partners AG. It trades about -0.07 of its total potential returns per unit of risk. Molecular Partners AG is currently generating about 0.02 per unit of volatility. If you would invest 670.00 in Molecular Partners AG on September 2, 2024 and sell it today you would lose (88.00) from holding Molecular Partners AG or give up 13.13% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tff Pharmaceuticals vs. Molecular Partners AG
Performance |
| Timeline |
| Tff Pharmaceuticals |
| Molecular Partners |
Tff Pharmaceuticals and Molecular Partners Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tff Pharmaceuticals and Molecular Partners
The main advantage of trading using opposite Tff Pharmaceuticals and Molecular Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tff Pharmaceuticals position performs unexpectedly, Molecular Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Partners will offset losses from the drop in Molecular Partners' long position.| Tff Pharmaceuticals vs. Gain Therapeutics | Tff Pharmaceuticals vs. In8bio Inc | Tff Pharmaceuticals vs. Lantern Pharma | Tff Pharmaceuticals vs. INmune Bio |
| Molecular Partners vs. Tff Pharmaceuticals | Molecular Partners vs. Eliem Therapeutics | Molecular Partners vs. Inhibrx | Molecular Partners vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |